#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Basal cell naevus syndrome Chronic myeloid leukaemia (in remission) Ichthyosis Glioblastoma multiforme Von Hippel-Lindau disease Cutaneous T-cell lymphoma recurrent Adenovirus infection Hyperphagia Human papilloma virus immunisation Mantle cell lymphoma Cerebellar ataxia Familial haemophagocytic lymphohistiocytosis Ischaemic stroke Pituitary-dependent Cushing's syndrome Homocystinuria More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung Primary biliary cholangitis – Trials in Disease Pituitary-dependent Cushing’s syndrome – Trials in Disease Idiopathic inflammatory myopathy – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Phenylketonuria – Treatment Combined immunodeficiency – Diagnostics Chordoma – Life with Disease Mantle cell lymphoma stage II – Treatment Acquired haemophilia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Prx005 Nystatin Triptorelin Lorlatinib Eptinezumab Methoxsalen Tx200-Tr101 Art6043 Dsimc Tildacerfont Gedatolisib Human Vaccinia Immunoglobulin Lutikizumab Istem-01 Darunavir Ciclosporin A Potato Starch Alendronic Acid Acetylsalicylic Acid Ph. Eur. Poractant Alfa More therapies…

    Learn about Your Condition

    Proteus syndrome Anogenital dysplasia Pyelonephritis acute Endometrial cancer Subarachnoid haemorrhage Wheezing Agitation Adenomyosis Pemphigus Metabolic syndrome Juvenile spondyloarthritis Neurotrophic keratopathy Gaucher's disease type I Ophthalmoplegia Pituitary tumour benign More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatocellular carcinoma

  • A study to evaluate the safety and effectiveness of PF-08634404 and ipilimumab in adults with advanced or spreading liver cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Ipilimumab
    France Germany Italy Spain

  • A study to evaluate the safety and effectiveness of AZD9793 in adults with advanced or metastatic liver cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Spain

  • Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Nephroblastoma
    • Rhabdoid tumour
    • Desmoplastic small round cell tumour
    Investigated Drugs:
    • 7-Ethyl-10-Hydroxycamptothecin
    Spain

  • Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    • Pancreatic carcinoma
    • Gastric cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Germany

  • Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Atezolizumab
    • Lenvatinib
    Austria Belgium Bulgaria Croatia Estonia Finland +6

  • A study comparing how lenvatinib capsules are absorbed in the body in healthy volunteers under fasting and fed conditions

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    • Endometrial cancer
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Lenvatinib
    Portugal
Previous Page
1 … 5 6 7 8 9 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!